CD4 and neoplasm: However, there is mounting evidence in support of cytotoxic CD4+ T cells as potential anti-tumor agents, involved in MHC-II-mediated tumor killing (Nagasaki et al., 2020; Oh et al., 2020; Sacher et al., 2020).